Viewing nowCombinationTuberon Tablets 60/10 mg (Pimasartan Potassium, Rosuvastatin)
Fimasartan Potassium Trihydrate Granules 150mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.

MFDS item code 201605333 · Approved 2016.08.31 · Insurance code 641906530
Treatment of hypertension and dyslipidemia; inhibits the progression of atherosclerosis and reduces cardiovascular disease risk
This medication is used for patients who need to take two medications, Pimasartan and Rosuvastatin together. Pimasartan helps treat essential hypertension. Rosuvastatin is used as an adjunct to diet to improve various dyslipidemic conditions, including hypercholesterolemia and hyperlipidemia. Additionally, this medication contributes to lowering total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, slowing the progression of atherosclerosis, and reducing the risk of cardiovascular diseases. It is particularly effective in reducing the risk of stroke, myocardial infarction, and vascular reintervention in high-risk patients over middle age. Therefore, this medication is used to improve hypertension along with hyperlipidemia and cardiovascular disease risk.
This drug is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, fimasartan and rosuvastatin. ○ Fimasartan 1. Adults The recommended dose of this drug is 30~60 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended that the drug be taken at the same time each day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks~12 weeks. 2. Older adults No initial dose adjustment is necessary in older adults 70 years of age or younger. (See section 9. Administration to older adults under Precautions for Use.) 3. Patients with renal impairment No dose adjustment is necessary in patients with mild~moderate renal impairment (creatinine clearance 30~80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment at 30 milligrams once daily and do not exceed 60 milligrams daily. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. Do not administer this drug to patients with moderate~severe hepatic impairment (see section 2. Patients in whom the drug must not be administered and section 10. Administration to patients with hepatic impairment under Precautions for Use). 5. Patients with reduced effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with reduced effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Patients in whom the drug should be used with caution under Precautions for Use.) ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Older adults No dose adjustment is necessary. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this drug at a dose of 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 5. Race Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of this drug at a dose of 40 milligrams is contraindicated in some of these patients. Patients taking fimasartan and rosuvastatin concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters; therefore, if pregnancy is confirmed, it should be stopped immediately. Individuals with allergic reactions to the components of this medication or who are pregnant or potentially pregnant, as well as nursing individuals, should not take it. It is safe not to take this medication for patients with moderately to severely impaired liver function, biliary obstruction, muscular disorders, or severely impaired renal function. Patients with low blood volume or sodium, impaired kidney function, or certain heart conditions should be closely monitored for risks of hypotension or worsening renal function when taking this medication. This medication may affect liver function, so liver function tests should be performed regularly before and during use, especially for patients with a history of liver diseases. Muscle-related adverse effects such as myalgia, muscle weakness, myopathy, or rhabdomyolysis may occur, so if these symptoms appear, inform a healthcare professional immediately and stop taking the medication. This medication may interact with several other drugs, so if the patient is currently taking other medications, it is essential to inform healthcare professionals, especially when combined with certain antibiotics, immunosuppressants, diuretics, or antihypertensives. Elderly individuals or those with genetic factors may react differently to the medication, so dosage adjustments may be necessary based on age and health status. Dizziness or drowsiness may occur while driving or operating machinery during this medication's use, so caution is advised. Safety and efficacy have not been established in children and adolescents under 18 years, so it is advisable not to use in this age group. This medication should be stored out of reach of children, and it is advisable not to transfer it to another container.
dyspepsia, nausea, fever, hepatitis, headache, dizziness, fainting, sedation, migraine, vomiting, upper abdominal pain, weakness, foreign body sensation, ALT elevation, γ-GTP elevation, liver enzyme level elevation, increased white blood cell count, urinary disorders, frequent urination, cough, hyperkalemia, arthralgia, insomnia, pruritus, angioedema, decreased platelet count, elevated serum creatine phosphokinase, muscle contraction, musculoskeletal rigidity, facial flushing, flushing, erectile dysfunction, constipation, abdominal pain, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscle weakness, ocular myasthenia, contusion, fainting, generalized pain, muscle cramps, gout, erectile dysfunction, chest pain, low back pain, edema, limb pain, peripheral edema, facial edema, fatigue, fever, neck/shoulder pain, fracture, arthralgia, osteoporosis, myalgia, pharyngitis, upper respiratory infection, sputum, rhinitis, epistaxis, bronchitis, unusual sensations, numbness, tremors, spinal stenosis, hypertonicity, anxiety, memory impairment, anorexia, gastroesophageal reflux, gastritis, functional gastrointestinal disorder, gastroenteritis, urinary incontinence, nephrolithiasis, dysuria, hyperlipidemia, dyslipidemia, hypoglycemia, hypertension, purpura, fatty liver, localized inflammation, soft tissue infection, pulmonary embolism, lymphadenopathy, unspecified abrasion, septal deviation, surgical intervention, postoperative pain, fever intolerance, recurrence of cancer, fall, pneumonia, lung disease, hemoptysis, exacerbation of rhinitis, pulmonary fibrosis, asthma, pulmonary granuloma, abnormal chest X-ray, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, fainting, generalized pain, muscle cramps, gout, erectile dysfunction, osteoarthritis, fracture, arthrosis, osteoporosis, muscle weakness, tendinitis, osteomyelitis, shoulder synovitis, synovitis, sciatica, jaw pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, deterioration of cerebral infarction, cerebral hemorrhage, arteriosclerosis, peripheral vascular disease, varicose veins, carpal tunnel syndrome, pulmonary tuberculosis, axillary pain, periorbital edema, allergy, chills, exacerbation of low back pain, nasal polyps, edema, peripheral edema, facial edema, fatigue, fever, pharyngitis, upper respiratory infection, sputum, rhinitis, epistaxis, bronchitis, unusual sensations, numbness, tremors, spinal stenosis, hypertonicity, insomnia, depression, anxiety, memory impairment, anorexia, gastroesophageal reflux, gastritis, diarrhea, constipation, functional gastrointestinal disorder, gastroenteritis, frequent urination, urinary incontinence, nephrolithiasis, worsening chronic kidney disease, dysuria, hyperlipidemia, dyslipidemia, hypoglycemia, cerebral infarction, herpes zoster, visual disturbances, tachycardia, hypertension, purpura, fatty liver, contusion
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture infiltration and should be kept at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's efficacy.
Orange convex octagonal film-coated tablets
30 tablets/box [10 tablets/PTP packaging ×3], 100 tablets/box [10 tablets/PTP packaging ×10], 30 tablets/box [10 tablets/Alu-Alu packaging ×3], 100 tablets/box [10 tablets/Alu-Alu packaging ×10]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate Granules 150mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 300mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 150mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.